Eton Pharmaceuticals, Inc.(ETON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ETON Eton Pharmaceuticals, Inc.

Closed Good Friday 04-17 16:00:00 EDT

14.34

+0.26

+1.85%

盘后14.34

+0.000.00%

16:05 EDT

High14.50	Low13.53	Vol257.21K
Open14.16	D1 Closing14.08	Amplitude6.89%
Mkt Cap384.56M	Tradable Cap297.37M	Total Shares26.82M
T/O3.64M	T/O Rate1.24%	Tradable Shares20.74M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"ETON","market":"US","secType":"STK","nameCN":"Eton Pharmaceuticals, Inc.","latestPrice":14.34,"timestamp":1744920000000,"preClose":14.08,"halted":0,"volume":257210,"hourTrading":{"tag":"盘后","latestPrice":14.34,"preClose":14.34,"latestTime":"16:05 EDT","volume":711,"amount":10195.74,"timestamp":1744920308611},"delay":0,"floatShares":20737208,"shares":26817535,"eps":-0.147634,"marketStatus":"Closed Good Friday","change":0.26,"latestTime":"04-17 16:00:00 EDT","open":14.16,"high":14.5,"low":13.53,"amount":3639637.5606,"amplitude":0.068892,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.147634,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1541739600000,"exchange":"NASDAQ","adjPreClose":14.08,"preHourTrading":{"tag":"盘前","latestPrice":14.25,"preClose":14.08,"latestTime":"09:10 EDT","volume":361,"amount":4957.590257,"timestamp":1744895435004},"postHourTrading":{"tag":"盘后","latestPrice":14.34,"preClose":14.34,"latestTime":"16:05 EDT","volume":711,"amount":10195.74,"timestamp":1744920308611},"volumeRatio":1.1159269382619637,"impliedVol":0.071,"impliedVolPercentile":0.0279},"requestUrl":"/m/hq/s/ETON","defaultTab":"news","newsList":[{"id":"2528109047","title":"B.Riley Financial Remains a Buy on Eton Pharmaceuticals (ETON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528109047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528109047?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 21:15","pubTimestamp":1744895755,"startTime":"0","endTime":"0","summary":"In a report released today, Madison Elsaadi from B.Riley Financial maintained a Buy rating on Eton Pharmaceuticals (ETON – Research Report), with a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/b-riley-financial-remains-a-buy-on-eton-pharmaceuticals-eton?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/b-riley-financial-remains-a-buy-on-eton-pharmaceuticals-eton?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ETON","BK4007"],"gpt_icon":0},{"id":"2527488394","title":"Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=2527488394","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527488394?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 21:07","pubTimestamp":1744722447,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals, Inc.  is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, and commercializing pharmaceutical products for rare diseases. The US$334m market-cap company announced a latest loss of US$3.8m on 31 December 2024 for its most recent financial year result. Many investors are wondering about the rate at which Eton Pharmaceuticals will turn a profit, with the big question being “when will the company breakeven?”Below we will provide a high-level summary of the industry analysts’ expectations for the company.According to the 3 industry analysts covering Eton Pharmaceuticals, the consensus is that breakeven is near. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$11m in 2025. The company is therefore projected to breakeven around a year from now or less!Using a line of best fit","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eton-pharmaceuticals-inc-nasdaq-eton-130727566.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","MNQmain","LU2210149790.SGD","USJW.SI","BK4112","NDAQ","IE00B3QW5Z07.USD","QLD","LU2095319765.USD","BK4585","IE00BGHQF748.EUR",".IXIC","USAW.SI","IE00B64PRP62.GBP","PSQ","TQQQ","NVIW.SI","IE00BKPKM429.USD","ETON","LU2210150020.SGD","BK4007","TSYW.SI","QID","NQmain","SQQQ"],"gpt_icon":1},{"id":"2524433201","title":"BUZZ-Eton Pharma falls after co licenses rare disease drug to Spanish company","url":"https://stock-news.laohu8.com/highlight/detail?id=2524433201","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524433201?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 22:56","pubTimestamp":1743519386,"startTime":"0","endTime":"0","summary":"BUZZ-Eton Pharma falls after co licenses rare disease drug to Spanish company** Shares of drug developer Eton Pharmaceuticals ETON.O fall ~3% to $12.58** ETON says it has out-licensed the non-U.S. commercial rights for its rare disease drug, Increlex, to Spain's Esteve Pharmaceuticals** Esteve will pay Eton 4 million euros  upfront for the licensing rights lasting up to ten years** ETON will still make the product and sell it to Esteve at a fixed price** Esteve also receives an option to permanently acquire the international rights in the future for up to 6 million euros** Increlex is used to treat growth failure in children and adolescents with severe primary insulin-like growth factor-1 deficiency** Including session move, ETON fell 2.6% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL3N3QF175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"gpt_icon":0},{"id":"2524123391","title":"Craig-Hallum Sticks to Their Buy Rating for Eton Pharmaceuticals (ETON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524123391","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524123391?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 21:35","pubTimestamp":1743514522,"startTime":"0","endTime":"0","summary":"In a report released today, Chase Knickerbocker from Craig-Hallum reiterated a Buy rating on Eton Pharmaceuticals (ETON – Research Report), with a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/craig-hallum-sticks-to-their-buy-rating-for-eton-pharmaceuticals-eton-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/craig-hallum-sticks-to-their-buy-rating-for-eton-pharmaceuticals-eton-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ETON"],"gpt_icon":0},{"id":"2524116054","title":"Eton Pharmaceuticals Agrees to License International Rights for Increlex to Esteve Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2524116054","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524116054?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 20:57","pubTimestamp":1743512235,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals (ETON) said Tuesday it has out-licensed commercial rights to Increlex in territories outside of the US to Esteve Pharmaceuticals.Increlex is indicated for the treatment of growth ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ETON","BK4007"],"gpt_icon":0},{"id":"2524197388","title":"BRIEF-Eton Pharmaceuticals Inc - Esteve To Pay Eur4 Million Up Front For Increlex Rights - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2524197388","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524197388?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 19:31","pubTimestamp":1743507067,"startTime":"0","endTime":"0","summary":"BRIEF-Eton Pharmaceuticals Inc - Esteve To Pay Eur4 Million Up Front For Increlex Rights - SEC FilingApril 1  - Eton Pharmaceuticals Inc ETON.O:ETON PHARMACEUTICALS INC - ESTEVE TO PAY EUR4 MILLION UP FRONT FOR INCRELEX RIGHTS - SEC FILINGETON PHARMACEUTICALS INC - ESTEVE HAS OPTION TO ACQUIRE INTERNATIONAL RIGHTS TO INCRELEX FOR EUR6 MILLION - SEC FILINGSource text: [ID:n0001437749-25-010358]Further company coverage: ETON.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF02C:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"gpt_icon":0},{"id":"2524872192","title":"Eton Pharmaceuticals Inc - Esteve Has Option to Acquire International Rights to Increlex for EUR6 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2524872192","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524872192?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 19:16","pubTimestamp":1743506183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF02C:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETON","BK4007"],"gpt_icon":0},{"id":"2524558194","title":"BRIEF-ESTEVE Signs License & Supply Agreement With Eton Pharmaceuticals With Global Rights For Increlex, Except For USA","url":"https://stock-news.laohu8.com/highlight/detail?id=2524558194","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524558194?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 19:02","pubTimestamp":1743505376,"startTime":"0","endTime":"0","summary":"BRIEF-ESTEVE Signs License & Supply Agreement With Eton Pharmaceuticals With Global Rights For Increlex, Except For USAApril 1 (Reuters) - Eton Pharmaceuticals Inc ETON.O:ESTEVE: SIGNS LICENSE & SUPPL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QE1M6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"gpt_icon":0},{"id":"2524194888","title":"Esteve: Signs License & Supply Agreement With Eton Pharmaceuticals With Global Rights for Increlex, Except for USA","url":"https://stock-news.laohu8.com/highlight/detail?id=2524194888","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524194888?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 19:01","pubTimestamp":1743505277,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QE1M6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETON","BK4007"],"gpt_icon":0},{"id":"2524192674","title":"Eton Pharmaceuticals Out-Licenses International Rights to Increlex®","url":"https://stock-news.laohu8.com/highlight/detail?id=2524192674","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524192674?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 19:00","pubTimestamp":1743505200,"startTime":"0","endTime":"0","summary":"Esteve Pharmaceuticals, S.A. will commercialize Increlex in all markets outside the U.S.“Esteve shares Eton’s dedication to putting patients first and we’re excited to partner with them to distribute this important treatment outside of the U.S. Esteve has the global infrastructure and established presence necessary to successfully commercialize Increlex in countries outside the U.S. This transaction will allow Eton to focus its efforts on the Company’s compelling growth opportunities within the U.S., including its threerare disease product launches planned for 2025, and eliminates the need for significant infrastructure investments that would have been required to commercialize Increlex outside the U.S.,” said Sean Brynjelsen, CEO of Eton Pharmaceuticals.Esteve will license the ex-U.S. rights for up to ten years and will also be receiving an option to acquire the international rights in the future. Eton will supply product to Esteve at a fixed transfer price, and the transaction does n","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eton-pharmaceuticals-licenses-international-rights-110000562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","ETON"],"gpt_icon":0},{"id":"2520152396","title":"Eton Pharmaceuticals Is Maintained at Buy by Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2520152396","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520152396?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 00:26","pubTimestamp":1742401560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ETON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 19, 2025 12:26 ET (16:26 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON"],"gpt_icon":0},{"id":"2520151931","title":"Eton Pharmaceuticals Price Target Raised to $24.00/Share From $21.00 by B. Riley Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2520151931","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520151931?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 23:59","pubTimestamp":1742399940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ETON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 19, 2025 11:59 ET (15:59 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RILY","ETON"],"gpt_icon":0},{"id":"2520181050","title":"Eton Pharmaceuticals price target raised to $26 from $23 at Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2520181050","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520181050?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 20:35","pubTimestamp":1742387739,"startTime":"0","endTime":"0","summary":"Craig-Hallum raised the firm’s price target on Eton Pharmaceuticals (ETON) to $26 from $23 and keeps a Buy rating on the shares following the compa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eton-pharmaceuticals-price-target-raised-to-26-from-23-at-craig-hallum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eton-pharmaceuticals-price-target-raised-to-26-from-23-at-craig-hallum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ETON"],"gpt_icon":0},{"id":"2520079029","title":"B. Riley Raises Price Target on Eton Pharmaceuticals to $24 From $21, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2520079029","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520079029?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:38","pubTimestamp":1742384320,"startTime":"0","endTime":"0","summary":"B. Riley Raises Price Target on Eton Pharmaceuticals to $24 From $21, Keeps Buy Rating","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ETON","RILY"],"gpt_icon":0},{"id":"2520081909","title":"Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2520081909","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520081909?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 18:50","pubTimestamp":1742381403,"startTime":"0","endTime":"0","summary":"NasdaqGM:ETON Earnings and Revenue Growth March 19th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 2.9%. Earnings per share  missed analyst estimates by 18%.Looking ahead, revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 8.4% growth forecast for the Pharmaceuticals industry in the US.The company's shares are up 4.1% from a week ago.We don't want to rain on the parade too much, but we did also find 1 warning sign for Eton Pharmaceuticals that you need to be mindful of.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eton-pharmaceuticals-full-2024-earnings-105003562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ETON"],"gpt_icon":0},{"id":"2520989469","title":"BUZZ-Eton Pharma falls after fourth-quarter loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2520989469","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520989469?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 01:17","pubTimestamp":1742318244,"startTime":"0","endTime":"0","summary":"BUZZ-Eton Pharma falls after fourth-quarter loss** Drug developer Eton Pharmaceuticals' ETON.O shares fall 2.2% to $13.39** Company posts fourth-quarter net loss of 2 cents per share vs analysts' estimate of break even per share, according to data compiled by LSEG** Company reports product revenue of $11.65 million vs est $10.53 million** As of last close, Eton Pharma's shares have more than tripled in the past 12 months  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nL4N3Q112J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"gpt_icon":0},{"id":"2520677126","title":"Eton Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2520677126","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520677126?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 21:32","pubTimestamp":1742304743,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings SummaryEton Pharmaceuticals Inc ETON.OQ reported a quarterly adjusted loss of 2 cents per share for the quarter en","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nL8N3Q1190:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON"],"gpt_icon":0},{"id":"2520601737","title":"Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2520601737","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520601737?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 20:00","pubTimestamp":1742299202,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals, Inc.  came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.09 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post a loss of $0.01 per share when it actually produced earnings of $0.02, delivering a surprise of 300%.Eton Pharmaceuticals , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $11.65 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 9.05%. This compares to year-ago revenues of $7.31 million. The company has topped consensus revenue estimates two times over the last four quarters.Eton Pharmaceuticals shares have added about 14.8% since the beginning of the year versus the S&P 500's decline of -3.5%.While Eton Pharmaceuticals has outperformed the market so far this year, the question that comes to investors' minds is: what's next for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eton-pharmaceuticals-inc-eton-reports-120002378.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ETON"],"gpt_icon":0},{"id":"2520628562","title":"Eton Pharmaceuticals Q4 2024 GAAP EPS $(0.02) Vs. $(0.09) YoY, Sales $11.65M Beat $10.53M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2520628562","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520628562?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 18:51","pubTimestamp":1742295113,"startTime":"0","endTime":"0","summary":"V","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44372942/eton-pharmaceuticals-q4-2024-gaap-eps-0-02-vs-0-09-yoy-sales-11-65m-beat-10-53m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Eton Pharmaceuticals Q4 2024 GAAP EPS $(0.02) Vs. $(0.09) YoY, Sales $11.65M Beat $10.53M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON"],"gpt_icon":0},{"id":"2520628591","title":"BRIEF-Eton Pharmaceuticals Q4 Net Income USD -598 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2520628591","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520628591?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 18:50","pubTimestamp":1742295045,"startTime":"0","endTime":"0","summary":"BRIEF-Eton Pharmaceuticals Q4 Net Income USD -598 Thousand\n\n\nMar 18 (Reuters) - Eton Pharmaceuticals Q4 basic EPS USD -0.02.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nPLXBC532F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.etonpharma.com","stockEarnings":[{"period":"1week","weight":0.198},{"period":"1month","weight":-0.0232},{"period":"3month","weight":-0.0049},{"period":"6month","weight":0.7174},{"period":"1year","weight":3.5669},{"period":"ytd","weight":0.0766}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.072708},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.010272},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.063788},{"month":4,"riseRate":0.428571,"avgChangeRate":0.02283},{"month":5,"riseRate":0.5,"avgChangeRate":-0.038613},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.049578},{"month":7,"riseRate":0.5,"avgChangeRate":-0.040643},{"month":8,"riseRate":0.666667,"avgChangeRate":0.138942},{"month":9,"riseRate":0.5,"avgChangeRate":0.04247},{"month":10,"riseRate":0.666667,"avgChangeRate":0.107507},{"month":11,"riseRate":0.666667,"avgChangeRate":0.077076},{"month":12,"riseRate":0.571429,"avgChangeRate":0.052607}],"exchange":"NASDAQ","name":"Eton Pharmaceuticals, Inc.","nameEN":"Eton Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Eton Pharmaceuticals, Inc.(ETON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Eton Pharmaceuticals, Inc.(ETON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Eton Pharmaceuticals, Inc.,ETON,Eton Pharmaceuticals, Inc.股票,Eton Pharmaceuticals, Inc.股票老虎,Eton Pharmaceuticals, Inc.股票老虎国际,Eton Pharmaceuticals, Inc.行情,Eton Pharmaceuticals, Inc.股票行情,Eton Pharmaceuticals, Inc.股价,Eton Pharmaceuticals, Inc.股市,Eton Pharmaceuticals, Inc.股票价格,Eton Pharmaceuticals, Inc.股票交易,Eton Pharmaceuticals, Inc.股票购买,Eton Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Eton Pharmaceuticals, Inc.(ETON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Eton Pharmaceuticals, Inc.(ETON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}